ALK
ALK manufactures immunotherapy products and provides prevention, diagnosis, and treatment of allergies.
ALK
Social Links:
Industry:
Health Care Health Diagnostics Manufacturing Pharmaceutical
Address:
Milan, Lombardia, Italy
Country:
Italy
Website Url:
http://www.alk.it
Status:
Active
Contact:
39-2-937631
Technology used in webpage:
Euro Irish Server Location
Similar Organizations
ABPM-ART Egészségügyi Szolgáltató és Kereskedelmi
ABPM-ART Egészségügyi Szolgáltató és Kereskedelmi manufactures and supplies medical devices, and diagnostic and laboratory equipment.
AI VIVO
AI VIVO is AI-based proprietary pharmacology platform designed to capture the dynamic effect of diseases and treatments at the organ level.
ALK Abelló
ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies.
Dr. Ausbüttel & Co.
Dr. Ausbüttel & Co. is a medical manufacturing firm that offers wound care, treatment, diagnosis, and other medical services.
High Research
High Research are manufacturers, distributors and dealers of pharmaceutical, diagnostic and related products.
Medac
Medac is a pharmaceutical company that supplies and manufactures various drugs and medical products for the treatment of diseases.
Vindon Scientific
Vindon Scientific designs, manufactures, and installs environmental testing and storage equipment for healthcare industries.
Founder
Official Site Inspections
http://www.alk.it Semrush global rank: 5.94 M Semrush visits lastest month: 1.18 K
- Host name: ec2-54-246-109-56.eu-west-1.compute.amazonaws.com
- IP address: 54.246.109.56
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "ALK"
ALK - Italy | A world leader in allergy immunotherapy
ALK è un'azienda farmaceutica globale orientata alla ricerca e focalizzata sulla prevenzione, la diagnosi e il trattamento delle allergie. Siamo i principali innovatori nel campo …See details»
Investors | ALK
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 ...See details»
ALK Technologies- Now Part of the Trimble Family!
“This is a significant milestone in ALK’s long history in transportation,” said Barry Glick, Executive Vice President and General Manager of ALK Technologies, who will continue to lead the …See details»
Executive Leadership Team | ALK
ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 ...See details»
ALK IN BREVE | ALK - Italy
ALK è quotata al NASDAQ di Copenaghen (OMX: ALK B). Cosa facciamo In qualità di leader mondiali nell'immunoterapia allergene-specifica (AIT), lavoriamo per migliorare la qualità della …See details»
Global presence | ALK
Apr 27, 2020 ALK's products can potentially benefit these patients. A global disease House dust mite allergy is the most common respiratory allergy, affecting around half of all people with a …See details»
Strategy | ALK
CEO Peter Halling says: “We want to sustain ALK’s growth for many years to come and leverage our insights and business platforms to help more people with allergies to a better life.The new …See details»
ALK - Crunchbase Company Profile & Funding
Organization. ALK . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Find More Contacts for ALK. Protected Content. Director, Director, …See details»
ALK - USA | A world leader in allergy immunotherapy
ALK is devoted to being there for people with allergies by developing pharmaceutical products that target the actual cause of allergy. Read more about what we do OUR MILESTONES …See details»
Cambia Paese | ALK - Italy
ALK-Abelló S.p.A. ∙ Via Pietro Paleocapa, 7 – 20121 Milano (MI). Italy .T +39 02 937631 - C.F. / P.IVA 04479460158 © 2018 ALK ∙ All rights reservedSee details»
Meet Our Partners: ALK - English - pharmacists.ca
Why does your organization belong to CPhA as an Organizational Affiliate? Pharmacists are often the first to consult patients on allergic rhinitis treatment options. We would like to work with …See details»
ALK POSITIVE
ALK Positive is a family of patients/survivors & caregivers, just like you, who are facing ALK-positive lung cancer with hope. Why join? • Be part of the largest, most active ALK-positive …See details»
Annual report 2024: ALK delivers 15% sales growth with profits up …
Feb 19, 2025 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the 2024 annual report. Following a robust performance in Q4, full-year results were in line with …See details»
ALK IT
Our mission is innovation and modern technologies that will make life easierSee details»
AZIONISTI | ALK - Italy
Nov 18, 2016 Azionista di controllo di ALK. La Lundbeck Foundation è il maggiore azionista di ALK e ne detiene il controllo con il 67% dei voti (40% del capitale). La fondazione ha stanziato …See details»
Science and technology | ALK
Nov 1, 2024 This approach was pioneered by ALK scientists and is now offered to millions of people with allergy at a global scale covering a broad range of major allergies. Biomarkers and …See details»
Annual report 2023: ALK delivers 9% sales growth with profits up …
Feb 8, 2024 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in …See details»
Workday and ALK
Evolves and it’s easy to see the new organization.” Intuitive and Innovative The ability to create well-run globalized processes— with more efficiency, compliance, quality, and clear …See details»
Digital innovation | ALK
ALK and McMaster researchers discover new cell that remembers allergies | ALK. Data-driven drug discovery. We are implementing cutting edge data platforms and new tools to enhance …See details»
Governance | ALK
ALK has zero-tolerance for employees engaging in any corrupt activities, as outlined in our anti-corruption policy. We regularly assess risks and adjust our compliance program accordingly. …See details»